The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes.
Phase of Trial: Phase IV
Latest Information Update: 15 Mar 2017
At a glance
- Drugs Liraglutide (Primary) ; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRA-DPP-4 CHINA
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 02 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Oct 2014 Planned End Date changed from 1 Dec 2014 to 1 Nov 2014 as reported by ClinicalTrials.gov.